Article Details

GlaxoSmithKline biopharma spinoff to deliver solid sales growth contrary to market scepticism ...

Retrieved on: 2021-04-19 11:15:00

Tags for this article:

Click the tags to see associated articles and topics

GlaxoSmithKline biopharma spinoff to deliver solid sales growth contrary to market scepticism .... View article details on hiswai:

Excerpt

The FTSE 100 group plans to split into two companies in 2022, consumer health and biopharma, and the outlook for the latter is regarded as the ...

Article found on: www.proactiveinvestors.co.uk

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo